N

National Institutes of Health (NIH) / National Library of Medicine

NIH's TrialGPT cuts clinical trial patient screening time by 40% using large language models

Curated & reviewed by Peter Korpak, Founder & Chief Analyst, 100SignalsHow we verify
40%Patient Screening Time Reduction
Equivalent (benchmarked on 1,000+ patient-criterion pairs)Accuracy vs. Human Clinicians

Vendor-reported figures — source: www.nih.gov

The Challenge

Finding the right clinical trial for interested patients is a time-consuming and resource-intensive process for clinicians, slowing down important medical research. Clinicians must manually navigate the vast and ever-changing catalog of trials listed on ClinicalTrials.gov, assessing eligibility criteria against individual patient profiles.

The Solution

NIH researchers from NLM and the National Cancer Institute developed TrialGPT, an LLM-powered framework that processes a patient summary, identifies relevant trials from ClinicalTrials.gov, excludes ineligible ones, and generates an annotated ranked list of trials with eligibility explanations for clinician review.

Results

In a pilot user study, clinicians using TrialGPT spent 40% less time screening patients while maintaining the same level of accuracy as manual review. TrialGPT's criterion-level eligibility predictions achieved nearly the same accuracy as human clinicians when benchmarked against over 1,000 patient-criterion pairs.

Key Takeaways

  • LLMs can match clinician-level accuracy on structured eligibility screening tasks, enabling meaningful time savings without sacrificing precision.
  • Ranking and annotating trial matches — rather than just flagging eligibility — is key to making AI-assisted trial matching actionable for clinicians.
  • Responsible AI deployment in clinical research requires fairness evaluation across diverse and underrepresented populations before broad rollout.

Share:

Have a similar implementation?

Share your customer's AI results and link it to your vendor profile.

Submit a case study →